These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24185312)

  • 1. Lectin-reactive anti-α-gal in patients with Crohn's disease: correlation with clinical phenotypes.
    Safaie P; Ham M; Kuang P; Mehta AS; Wang M; Cheifetz AS; Robson S; Lau D; Block TM; Moss AC
    Inflamm Bowel Dis; 2013 Dec; 19(13):2796-800. PubMed ID: 24185312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lectin-based immunoassay for aberrant IgG glycosylation as the biomarker for Crohn's disease.
    Shinzaki S; Kuroki E; Iijima H; Tatsunaka N; Ishii M; Fujii H; Kamada Y; Kobayashi T; Shibukawa N; Inoue T; Tsujii M; Takeishi S; Mizushima T; Ogata A; Naka T; Plevy SE; Takehara T; Miyoshi E
    Inflamm Bowel Dis; 2013 Feb; 19(2):321-31. PubMed ID: 23287897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein.
    Dubé R; Rook GA; Steele J; Brealey R; Dwek R; Rademacher T; Lennard-Jones J
    Gut; 1990 Apr; 31(4):431-4. PubMed ID: 2338269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of agalactosyl IgG in inflammatory bowel disease patients.
    Nakajima S; Iijima H; Shinzaki S; Egawa S; Inoue T; Mukai A; Hayashi Y; Kondo J; Akasaka T; Nishida T; Kanto T; Morii E; Mizushima T; Miyoshi E; Tsujii M; Hayashi N
    Inflamm Bowel Dis; 2011 Apr; 17(4):927-36. PubMed ID: 20824817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Gal titers in healthy adults and inflammatory bowel disease patients.
    Mangold A; Lebherz D; Papay P; Liepert J; Hlavin G; Lichtenberger C; Adami A; Zimmermann M; Klaus D; Reinisch W; Ankersmit HJ
    Transplant Proc; 2011 Dec; 43(10):3964-8. PubMed ID: 22172880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
    Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: a critical reappraisal with review of the literature.
    Annese V; Piepoli A; Latiano A; Lombardi G; Napolitano G; Caruso N; Cocchiara E; Accadia L; Perri F; Andriulli A
    Dis Colon Rectum; 2005 Jan; 48(1):57-64; discussion 64-5. PubMed ID: 15690658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in serum anti-alpha-galactosyl antibodies in patients with Crohn's disease and ulcerative colitis.
    D'Alessandro M; Mariani P; Lomanto D; Bachetoni A; Speranza V
    Clin Immunol; 2002 Apr; 103(1):63-8. PubMed ID: 11987986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease.
    Walmsley RS; Zhao MH; Hamilton MI; Brownlee A; Chapman P; Pounder RE; Wakefield AJ; Lockwood CM
    Gut; 1997 Jan; 40(1):105-9. PubMed ID: 9155585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
    Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel disease.
    Shinzaki S; Iijima H; Nakagawa T; Egawa S; Nakajima S; Ishii S; Irie T; Kakiuchi Y; Nishida T; Yasumaru M; Kanto T; Tsujii M; Tsuji S; Mizushima T; Yoshihara H; Kondo A; Miyoshi E; Hayashi N
    Am J Gastroenterol; 2008 May; 103(5):1173-81. PubMed ID: 18177457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
    Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
    World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
    Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
    Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum antibodies to cow's milk proteins in pediatric inflammatory bowel disease: Crohn's disease vs. ulcerative colitis.
    Lerner A; Rossi TM; Park B; Albini B; Lebenthal E
    Acta Paediatr Scand; 1989 Jan; 78(1):81-6. PubMed ID: 2919527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum antibodies to cow's milk proteins in pediatric inflammatory bowel disease. Crohn's disease versus ulcerative colitis.
    Lerner A; Rossi TM; Park B; Albini B; Lebenthal E
    Acta Paediatr Scand; 1989 May; 78(3):384-9. PubMed ID: 2741681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against Mycobacterium paratuberculosis in Crohn's disease.
    Walmsley RS; Ibbotson JP; Chahal H; Allan RN
    QJM; 1996 Mar; 89(3):217-21. PubMed ID: 8731566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum antibodies associated with complex inflammatory bowel disease.
    Elkadri AA; Stempak JM; Walters TD; Lal S; Griffiths AM; Steinhart AH; Silverberg MS
    Inflamm Bowel Dis; 2013 Jun; 19(7):1499-505. PubMed ID: 23702714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic associations of Crohn's disease with antibodies to flagellins A4-Fla2 and Fla-X, ASCA, p-ANCA, PAB, and NOD2 mutations in a Swiss Cohort.
    Schoepfer AM; Schaffer T; Mueller S; Flogerzi B; Vassella E; Seibold-Schmid B; Seibold F
    Inflamm Bowel Dis; 2009 Sep; 15(9):1358-67. PubMed ID: 19253375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin G (IgG), IgG1, and IgG2 determinations from endoscopic biopsy specimens in control, Crohn's disease, and ulcerative colitis subjects.
    Rüthlein J; Ibe M; Burghardt W; Mössner J; Auer IO
    Gut; 1992 Apr; 33(4):507-12. PubMed ID: 1582596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.